“The successful TGA approval for PromarkerD software as an IVD forms part of Proteomics International’s ongoing strategy to gain regulatory approvals for the pioneering test in multiple jurisdictions. … Given Proteomics’ ambitions to execute licensing transactions globally, the granting of the Indonesian patent secures another potentially lucrative jurisdiction.”
Article: Proteomics International Laboratories secures Indonesian patent for its diagnostic test
